Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section
Status:
Suspended
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of local wound infiltration of
EXPAREL® (liposomal bupivacaine) with bupivacaine HCl compared to active control with
bupivacaine HCl alone following elective primary or repeat cesarean delivery with spinal
anesthesia.